Qiagen (QGEN) advanced 7.3% on a report that discussions between the company and a potential buyer are speculated to have advanced. At least one possible buyer is in advanced talks to buy Qiagen (QGEN ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Qiagen N.V. is betting that drug discovery agents need a trustworthy knowledge foundation as much as capable models. For biopharma companies, that means giving agents information with clear provenance ...

Qiagen steht weiter zum Verkauf – und offenbar rücken dabei vor allem Finanzinvestoren in den Vordergrund. Nach Informationen des „Manager Magazins“ interessieren sich neben KKR, EQT und Advent ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

DNA extraction is the process of isolating genomic (or plasmid) DNA from cells or tissue and separating it from proteins, lipids, RNA, and other cellular debris so it is pure enough for downstream ...

You don't want to miss this! To permanently access this App Note for free, fill out the short form below. Genomic DNA (gDNA) extraction is a critical step in molecular biology workflows, directly ...

Qiagen NV (QGEN) soared 11% after a report that the European molecular testing company is seeing early takeover interest from private equity firms including EQT AB and Advent. Deliberations are ...

July 9 (Reuters) - Diagnostics company Qiagen (QIA.DE), opens new tab is drawing early takeover interest from buyout firms, including EQT ‌AB (EQTAB.ST), opens new tab, Advent and KKR (KKR.N), opens ...

Mounting preclinical evidence demonstrates the importance of the human microbiome in health and disease. Saliva presents a particularly appealing medium for microbiome research due to its non-invasive ...

- The global DNA/RNA extraction market is projected to grow at 8.4% CAGR, reaching $16.4B by 2033, driven by genomics, precision medicine, and automation adoption. - Automated extraction leads with 11 ...